NasdaqGS:MASIMedical Equipment
Should Masimo’s 2028 Margin Ambitions and Apple Verdict Upside Require Action From Masimo (MASI) Investors?
Earlier in 2025, Masimo held its Investor Day and outlined a multi-year plan targeting 7%–10% revenue CAGR and about 30% operating margins by 2028, while also completing the sale of its Sound United consumer audio unit to Samsung’s Harman to sharpen its focus on core healthcare monitoring.
The company also secured a very large US$634 million jury verdict in a patent dispute with Apple over blood-oxygen technology, though the outcome remains uncertain as Apple plans to appeal, adding both...